Biotech Showcase 2012_ReNeuron – Video

Posted: January 29, 2013 at 9:49 pm




Biotech Showcase 2012_ReNeuron
ReNeuron is a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need. We have used our unique stem cell technologies to develop cell-based therapies for significant disease conditions where the cells can be readily administered "off-the-shelf" to any eligible patient without the need for additional drug treatments. Our lead therapeutic candidate is our ReN001 stem cell therapy for the treatment of patients left disabled by the effects of a stroke. This treatment is currently in clinical development. We are also developing stem cell therapies for other conditions such as critical limb ischaemia, a serious and common side effect of diabetes, and blindness-causing diseases of the retina. http://www.reneuron.com View ReNeuron #39;s Alliance for Regenerative Medicine member profile at alliancerm.org

By: AllianceRegenMed

Read more from the original source:
Biotech Showcase 2012_ReNeuron - Video

Related Posts